ABSTRACT
The possibility of a relationship between thyroid gland, brain and behaviour has captured the attention of clinicians and researchers for more than two centuries (Whybrow and Prange, 1981) . Although, a relationship between clinical disorders of the thyroid gland and psychiatric morbidity has been well established, the significance of the association between thyroid functioning and primary psychiatric disorders is much less clear.
Many studies in seventies and eighties reported elevated total thyroxin (T 4 ) and free thyroxin (FT 4 ) levels in acute depressive illness which normalized after recovery (Whybrow et al ,1972; Takahashi et al.,1974; Kirkegaard et al.,1981; Linnoila et al.,1982) . However, others found either no difference or decreased level of thyroxin during acute phase of depression. (Kirkegaard et al ,1977; Rinieris et al.,1978 : Linnoila etal, 1979 Kjellman etal, 1983; Callaway et al ,1984; Joffe et al.,1985; Sternback et al., 1985; Baumgartner et al.,1988) . A study by Sokolov et al. (1994) reported elevated T 4 (but not FT 4 ) in depressed adolescent patients as compared to controls. Similarly, conflicting findings have been reported about total triiodothyronine (T 3 ) during acute depressive illness (normal level of T 3 as reported by Kirkegaard etal., 1977; Rinieris et al.,1978; Kirkegaard and Faber, 1981; Kjellman et al.,1983; Callaway+ et al.,1984; Roy-Byrne et al.,1984 and decreased T 3 level as reported by Linnoila et al.,1979; Joffe et al.,1985; Orsulak et al.,1985) . Thus various studies have yielded a conflicting data about changes in thyroid functioning during acute depression However, the most consistent findings have been elevated total Thyroxin (TJ or free thyroxin (F-TJ "within the euthyroid range" that decrease with treatment (Joffe, 1990) .
In India, very little work has been done in this field. Boral et al. (1979) studied 12 patients of manic depressive psychosis and found lower levels of total thyroxin (T 4 ) and total triiodothyronine (T 3 ) in depressive patients and higher levels in manics as compared to controls. Same authors, in another study (Boral et al.,1980) again found low levels of total thyroxin (TJ and total triiodothyronine (T 3 ) and elevated thyrotropin (TSH) in depressed patients.
The present study was planned to study the basal thyroid functions in drug naive patients with first episode of depression and to compare the findings with normal controls.
MATERIAL AND METHOD
Between Jan. and Dec. 1997, 33 drug naive depressive patients in the age range of 18-60 years, having first episode of illness reporting at OPD of our institute and diagnosed as per DCR (Diagnostic Criteria for Research) of ICD-10 (WHO, 1992) were selected. 31 healthy controls were taken from dermatologicai clinic. A careful history, thorough physical examination and relevant laboratory investigations were performed to rule at any evidence of endocrinological, hepatic, renal, cardiac or ether chronic systemic illness, significant alcoholism or other substance abuse and pregnancy or oral contraceptive use (in case of female subjects). The depressive patients were rated on Hamilton's depressive rating scale (Hamilton,1967) to assess the seventy of depression The controls were matched with the depressive patients with respect to age, sex and socio economic status.
The blood sample was drawn in the fasting state between 8 am to 9 am and total thyroxin (T 4 ), total triiodothyronine (T 3 ) and thyroid stimulating hormone (TSH) were estimated using enzyme-immuno assay. The results obtained were analysed using statistical package of social sciences, version -7.0 (SPSS-7.0). Table 1 shows the comparison of sociodemographic variables between the depressive and the control groups. There was no significant difference between the two groups with respect to age, sex, marital status, socio-economic status, domicile, education and occupation. In Table 2 shows the comparison of mean values of total thyroxin (T 4 ), total triiodothyronine (T 3 ) and thyroid stimulating hormone (TSH) between the depressive and the control groups. The mean value of total thyroxin (T 4 ) was significantly higher in the depressive group as compared to the control group (p<0.05). The mean value of total triiodothyronine (T 3 ) was lower in case of depressives as compared to controls, although the difference just escaped the statistical significance. There was no difference between the mean value of thyroid stimulating hormone (TSH) between the two groups. The ratio of total triiodothyronine to total thyroxin (T 3 /T 4 ) was higher in control group as compared to the depressive group. Table 3 shows the mean values of total T 4 , total T 3 and TSH in depressive patients with respect to important clinical variables. There was no significant difference between depressive patients with and without the presence of psychotic features and with and without the presence of somatic syndrome with respect to total T 3 and total T 4 . However, depressive patients with psychotic features had significantly higher mean values of thyroid stimulating hormone (TSH) as compared to those without psychotic features (p<0.05). The depressive patients with good as well as poor premorbid global functioning had comparable values of total T 3 , total T 4 and TSH.
RESULTS
The data was further analyzed to find out the frank as well as subclinical (Gold et al., 1981) thyroid abnormalities in the two groups. A total of 3 depressive patients (9%) had grade II hypothyroidism and one (3%) had grade I hypothyroidism. One (3%) depressive patient had frank hyperthyroidism. None of the controls had either hypo or hyperthyroidism.
DISCUSSION
Many of the previous studies done in this field had various methodological flaws in the sample selection e.g. including the patients having chronic resistant illness or being on psychotropic medication. The present study included only drug-naive patients having first episode of depressive illness. This way, the nonspecific effects of chronicity of illness and pharmacological agents on thyroid functions were taken care of.
The most significant finding of the study was elevated levels cf total thyroxin (T 4 ) in the depressive patients in the acute phase of illness as compared to healthy controls. This is in agreement with most of the earlier studies (Whybrow et al.,1972; Takahashi et al.,1974; Kirkegaard and Faber,1981; Muller and Boning, 1988) .
Bauer and Whybrow (1988) proposed that elevated total thyroxin (T 4 ) during acute
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depression is a compensatory phenomenon so as to help in increasing the catecholamine neurotransmission tor the alleviation of depressive affect. On the other hand, Joffe et al. (1984) and Joffe and Levitt (1990) proposed that relative increase in total thyroxin (T 4 ) during acute depression is not compensatory, but is pathological indicating a relative state of hyperthyroidism and a substantial decrease in thyroxin level is required for recovery. In this study, the levels of thyroxin (T 4 ) were not preformed after the recovery and this remains one of its limitations. We did not find any difference with respect to thyroid stimulating hormone (TSH) levels between the depressive and the control groups. This finding is similar to most of the previous studies (Takahashi et al., 1973; Linnoii i et al., 1979; Gold etal.,1981; Loosen and Prange.1982) .
The literature regarding total triiodothyronine (T 3 ) during acute depression is less consistent. Takahashi et al. (1974) found marginally elevated T 3 during acute depression wi lerea? most of the other studies reported either norma 1 or decreased total T 3 during acute depression (Kirkegaard and Faber,1981; Kjellmanetal.,1983; Sternbacketal.,1985; Joffe et al., 1985; Orsulak et al., 1985; Baumgartner et al.,1988) . Muller and Boning (1988) found elevated thyroxin (T 4 ) and decreased triiodothyronine (T 3 ) during acute depression and concluded that this finding may indicate that there is some defect in the conversion of thyroxin (T 4 ) to triiodothyronine (T 3 ). We found that the mean value of total triiodothyronine (T 3 ) was lower in depressive patients as compared to controls, though the difference just escaped statistical significance. The exact significance of this findings is not clear. However, alongwith elevated levels of total thyroxin (T 4 ) and decreased triiodothyronine to thyroxin ratio (T 3 / T 4 ), the decreased triiodothyronine (T 3 ) in depressive patients indicate that the conversion of thyroxin (T 4 ) to triiodothyronine (T 3 ) may be defective in the depressive illness.
Joffe et al. (1992) did not find any difference between patients with melancholic and non-melancholic depression with respect to total thyroxin (T 4 ), total triiodothyronine (T 3 ) and thyroid stimulating hormone (TSH). In this study, we did not find an/difference with respect to any of the thyroid parameters between the depressive patients with and without the presence of somatic syndrome. Joffe and Levitt (1990) found significantly lower total triiodothyronine (T 3 ) and significantly higher thyroid stimulating hormone (TSH) in patients with psychotic depression as compared to nonpsychotic depression. Our study found that depressive patients with psychotic features had significantly higher (p<0.05) value of thyroid stimulating hormone (TSH) as compared to those without psychotic features, though there was no significant difference between the two with respect to total thyroxin (T 4 ) and total triiodothyronine (T 3 ). Even in the absence of low values of total thyroxin (T 4 ) and total triiodothyronine (T 3 ), elevated levels of thyroid stimulating hormone (TSH) indicate the presence -of subclinical hypothyroidism in depressive patients with the presence of psychotic features as suggested by Joffe and Levitt (1990) .
Apart from subtle changes in the thyroid functions, many studies have found overt thyroid abnormalities in a minority of depressive patients (Goldetal.,1981; Diaz-Cabaletal.,1986; Joffe et al.,1992) . We found a total of a 4 (12%) patients having grade I and grade II (Gold et al.,1981) hypothyroidism and 1 patient (3%) having frank hyperthyroidism.
In the conclusion, we would like to emphasize that this study supports the view that there are subtle but significant abnormalities in the basal level of thyroid hormones in acute depressive illness. There is a need to continue the research efforts in this field to further clarify the aetiopathological significance of altered thyroid functioning in depressive illness.
